Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has discussed the Terminally Ill Adults (End of Life) Bill with his counterpart in the Welsh Government.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Government remains neutral on the matter of assisted dying and the passage of the Terminally Ill Adults (End of Life) Bill. The Bill remains a matter for the hon. Member for Spen Valley who, as its sponsor, leads on policy and engagement in relation to the Bill.
Ministers in the Department have had no discussions about the Bill with counterparts in the Welsh Government.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the potential cost to the public purse of the Terminally Ill Adults (End of Life) Bill.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
I refer the hon. Member to the impact assessment.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the Terminally Ill Adults (End of Life) Bill on the NHS budget.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
I refer the hon. Member to the impact assessment.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will support the establishment of Centres of Excellence for each less survivable cancer type.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
To support cancer care for rarer and less survivable cancer type, the Government is committed to helping the National Health Service to diagnose all cancers earlier and to treat them faster.
The Government is also committed to improving waiting times for cancer treatment, so that people with cancer, including less survivable cancer, can get access to the care they need more quickly. As the first step to ensuring faster diagnosis and treatment, the National Health Service is delivering an extra 40,000 operations, scans, and appointments each week.
Moreover, full roll out of non-specific symptom (NSS) pathways, designed to speed up the diagnosis of cancer, has been achieved across England. NSS pathways introduce a route to possible diagnosis for patients who display symptoms that could indicate cancer, but which do not align to specific cancers, often the case for less survivable cancers. The new non-specific pathway complements current cancer diagnostic pathways, as well as providing elements that can be applied to existing pathways. The National Cancer Plan, planned for publication later in 2025, will include further details on how we will improve outcomes for cancer patients, including those with rarer and less survivable cancer, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology. The Department ran a public Call for Evidence to determine priorities for the plan; responses are currently being analysed. The plan will seek to improve every aspect of cancer care, to improve the experience and outcomes for people with cancer, including less survivable cancer.
For these reasons, the Department does not currently have plans to support the establishment of Centres of Excellence for each survivable cancer type.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will support the (a) rollout and (b) expansion of testing for (i) hepatitis B, (ii) hepatitis C, (iii) HIV, (iv) other precursor conditions to less survivable cancers and (v) NHS England’s risk-stratified Community Liver Health Check programme.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Testing for hepatitis B, C, and HIV is available through a variety of routes including, primary care, sexual health services and targeted testing to reach groups most at risk of infections. NHS England’s opt-out testing programme operates at several emergency departments and tests all adults blood test for hepatitis B, C, and HIV, unless they opt out. NHS England is exploring whether funding can be identified to allow the programme to continue beyond the current financial year.
The Department supports testing for precursor conditions to less survivable cancers through several programmes. The NHS Cancer Programme works to detect more hepatocellular carcinomas, namely liver cancer, at an early stage. Six-monthly liver ultrasound surveillance for patients with cirrhosis or advanced fibrosis is carried out to identify liver cancers earlier. In 2025/26, community liver health checks will continue to be rolled out across 20 areas to identify patients with cirrhosis or advanced fibrosis.
To speed up diagnosis of cancer, a full roll-out of non-specific symptom pathways has been achieved in England. These introduce a diagnosis route for patients displaying symptoms not aligned to specific cancers. This programme has provided funding to Cancer Alliances in 2023/24 and in 2024/25 to invest in local liver surveillance programmes.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the link between lung health and the adequacy of smoking cessation services in (a) Newcastle-under-Lyme constituency and (b) Staffordshire.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
We are increasing our efforts to support smokers to quit and have invested an additional £70 million, this year and last, for local stop smoking services, in England. It is for local authorities to determine and commission the most appropriate stop smoking services for their area.
No specific assessment has been made of the impact of stop smoking services on lung health in these areas. However, we have commissioned an independent evaluation of the impact of our additional funding to stop smoking services, in which we look at partnerships with health providers.
There is also an established referral pathway between the NHS Targeted Lung Health Programme in University Hospital North Midlands and the local stop smoking service. The local NHS Targeted Lunch Health Check Programme also previously ran a pilot to offer smoking cessation support to patients through community pharmacies.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate she has made of the number of people with chronic obstructive pulmonary disease in (a) Newcastle-under-Lyme constituency and (b) Staffordshire.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The House of Commons Library has published estimates at a constituency level for a variety of health conditions, including chronic obstructive pulmonary disease (COPD), with further information available at the following link:
https://commonslibrary.parliament.uk/constituency-data-how-healthy-is-your-area/
For the Newcastle-under-Lyme constituency, this data shows an estimated prevalence of 2.45% for COPD. This is higher than the estimated prevalence for the West Midlands and England, with both having a prevalence of 1.85%. These figures are based on modelled estimates, derived from data published by NHS Digital in the Quality and Outcomes Framework (QOF) 2022/23. Integrated care board (ICB) level QOF data for the same 2022/23 period is available at the following link:
This shows that for the NHS Staffordshire and Stoke-on-Trent ICB, the COPD register consists of 26,564 patients, and has a prevalence rate of 2.24%.
The latest QOF data that has been published by NHS England is for the 2023/24 period, and is available at the following link:
This shows that for the NHS Staffordshire and Stoke-on-Trent ICB, the COPD register consists of 27,019 patients, and has a prevalence rate of 2.26%.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential implications for his policies of the report by Asthma Lung UK entitled Lung conditions kill more people in the UK than anywhere in Western Europe, published on 28 February 2022.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The report from Asthma + Lung UK highlights the relatively high mortality rate in the United Kingdom from lung conditions such as chronic obstructive pulmonary disease (COPD) and asthma. It asks for better and faster diagnosis, new treatments, new technology, and more action on prevention. These are consistent with the Government’s policies and priorities.
The Government has committed to delivering three big shifts that the National Health Service needs to be fit for the future: from hospital to community, from analogue to digital, and from sickness to prevention. All of these are relevant to improving respiratory health in all parts of the country.
This will support earlier diagnosis, better joint working between services, and greater use of apps and wearable technology will all help people manage their long-term conditions, including respiratory conditions, closer to home. Earlier diagnosis of conditions will help prevent deterioration and improve survival rates. Taking action to reduce the causes of the biggest killers, such as enabling a smoke free generation through the Tobacco and Vapes Bill, can further help prevent lung conditions.
On COPD and asthma specifically, the NHS is investing in the provision of more and better rehabilitation services for respiratory patients. This has the objective of improving outcomes through early diagnosis including via spirometry tests, and through increased access to treatments.
The NHS RightCare COPD pathway has been rolled out nationally and defines the optimal service for people with COPD. Furthermore, the National Respiratory Audit Programme aims to improve quality of care, services, and clinical outcomes for patients with asthma and COPD, by collecting and providing data on a range of indicators and pulmonary rehabilitation activity. A national programme of work is underway to support systems with improving access to Pulmonary Rehabilitation for the eligible population. Pulmonary rehabilitation is effective for people with COPD, improving exercise capacity or increased quality of life in 90% of patients who complete a programme.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent steps he has taken to increase the level of access to NHS dentists by people in a) Newcastle-under-Lyme and (b) Staffordshire.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Government plans to tackle the challenges for patients trying to access National Health Service dental care with a rescue plan to provide 700,000 more urgent dental appointments and recruit new dentists to the areas that need them most. To rebuild dentistry in the long term, we will reform the dental contract with the sector, with a shift to focus on prevention and the retention of NHS dentists.
The responsibility for commissioning primary care services, including NHS dentistry, to meet the needs of the local population has been delegated to the integrated care boards (ICBs) across England. For the Newcastle-under-Lyme constituency and Staffordshire, this is the Staffordshire and Stoke-on-Trent ICB. ICBs have been asked to start making extra urgent dental appointments available from April 2025. The Staffordshire and Stoke-on-Trent ICB is expected to deliver 16,190 additional urgent dental appointments as part of the scheme.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of children and young people waiting for an ADHD assessment in (a) Newcastle-under-Lyme and (b) Staffordshire.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
There is, at present, no single established dataset that can be used to monitor waiting times for assessment and diagnosis for attention deficit hyperactivity disorder (ADHD) for individual organisations or geographies in England. Although the data requested is not held centrally, it may be held locally by individual National Health Service trusts or commissioners.
For the first time, NHS England published management information on ADHD waits at a national level on 29 May 2025 as part of its ADHD data improvement plan; it will soon release technical guidance to integrated care boards (ICBs) to improve recording of ADHD data, with a view to improving the quality of ADHD waits data and publishing more localised data in future.
NHS England has established an ADHD taskforce which is bringing together those with lived experience with experts from the NHS, education, charity and justice sectors to get a better understanding of the challenges affecting those with ADHD, including in accessing services and support, with the report expected in the summer. NHS England has also captured examples from ICBs who are trialling innovative ways of delivering ADHD services and is using this information to support local systems to tackle ADHD waiting lists and provide support to address people’s needs.